Physician

Matthew David Smith, M.D.

According to 2025 Medicare claims, Matthew Smith, M.D. (NPI: 1790929248) practices family practice in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Christian, KY. This provider's primary affiliated billing organization is GENERATIONS PRIMARY CARE PSC (NPI: 1831412519; TIN: 270702287) and primary practice location at 42240-8725. Smith is affiliated with the Imperium Clinical Partners (ACO ID: A4945), participating under the MSSP model.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 370 traditional Medicare patients, billed 2,499 HCPCS/CPT codes, and received $113,002 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 9,204 prescription claims across 629 beneficiaries totaling $518,477 in drug costs, led by Ozempic (Semaglutide). DME data shows 63 claims. Open Payments data shows 1 records totaling $25. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $144,107 and ending at $113,002. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $21,233 and ending at $13,735.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	815	3,508	$144,107
2016	631	2,548	$107,127
2017	594	2,606	$108,342
2018	570	2,716	$97,856
2019	883	4,104	$144,250
2020	670	3,279	$116,275
2021	733	3,596	$166,240
2022	583	3,042	$127,752
2023	420	1,993	$97,431
2024	370	2,499	$113,002

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	612	8,946	$434,062
2016	611	9,336	$427,920
2017	643	9,144	$428,837
2018	675	8,861	$507,844
2019	820	8,752	$527,988
2020	692	9,098	$431,145
2021	817	9,885	$558,724
2022	784	8,838	$520,413
2023	727	8,924	$587,802
2024	629	9,204	$518,477

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	95	251	$6,306
2016	73	260	$7,148
2017	72	170	$5,546
2018	25	159	$3,556
2019	27	139	$2,909
2020	30	212	$9,230
2021	27	124	$7,158
2022	N/R	122	$9,968
2023	N/R	125	$9,729
2024	N/R	63	$9,019

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	196	196	$123
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	227	422	$81
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	215	319	$55
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	86	332	$42
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	129	204	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	55	2,280	$72,916
Eliquis	Apixaban	94	3,219	$61,332
Xarelto	Rivaroxaban	30	1,782	$32,222
Nucynta	Tapentadol Hcl	11	330	$30,681
Jardiance	Empagliflozin	17	990	$18,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	15	$7,825
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	16	$684
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	17	$308
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	15	$202

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$25	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Matthew David Smith, M.D.?

Tedicare shows public-source Medicare data for Matthew David Smith, M.D. (NPI 1790929248), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Matthew David Smith, M.D. have ACO affiliation data?

Matthew David Smith, M.D. is shown with ACO affiliation data for Imperium Clinical Partners (MSSP, ACO ID A4945).

What billing organization is linked to Matthew David Smith, M.D.?

Matthew David Smith, M.D. is linked to GENERATIONS PRIMARY CARE PSC (billing NPI 1831412519) in the available physician profile data.

Does Matthew David Smith, M.D. have Open Payments data?

Matthew David Smith, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.